BackGreenLight Biosciences- Warrants (30/09/2027) Overview

GreenLight Biosciences- Warrants (30/09/2027) Long Term Debt

Latest long-term debt for GRNAW: $60M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$59.56M
151.46% YoYΔ $35.87M vs prior year quarter

Peer trimmed avg / median

Loading

GreenLight Biosciences- Warrants (30/09/2027) Long Term Debt History

Loading

GreenLight Biosciences- Warrants (30/09/2027) vs. peers: Long Term Debt Comparison

Loading

GreenLight Biosciences- Warrants (30/09/2027) Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GreenLight Biosciences- Warrants (30/09/2027) (GRNAW) FAQ

As of the most recent data (March 2023), GRNAW shows a long-term debt of $60M. That compares with $24M in the prior-year period — up 151.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GRNAW's long-term debt is now $60M (was $24M) — a 151.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether GreenLight Biosciences- Warrants (30/09/2027) is outperforming or lagging.

Tracking GRNAW's long-term debt over time shows whether GreenLight Biosciences- Warrants (30/09/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $60M That compares with $24M in the prior-year period — up 151.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has GreenLight Biosciences- Warrants (30/09/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $60M) with ownership activity and broader fundamentals.